Advertisement

Topics

Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft

2010-07-15 17:00:00 | BioPortfolio

Summary

This is a multi center, prospective study designed to demonstrate the safety and performance of the GARDEX Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) interventions.

Study Design

Allocation: Non-Randomized, Control: Historical Control, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Saphenous Vein Graft Disease

Intervention

GARDEX™

Location

Bnei Zion Medical Center
Haifa
Israel
33394

Status

Recruiting

Source

Gardia Medical

Results (where available)

View Results

Links

Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [1158 Associated Clinical Trials listed on BioPortfolio]

Radial Artery vs. Saphenous Vein Grafts in Coronary Artery Bypass Surgery

VA patients with coronary artery disease and who have agreed to undergo coronary artery bypass graft surgery would be randomized to receive either radial artery or saphenous vein to the st...

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts

This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vei...

Evaluating the Role of Thrombin in Saphenous Vein Graft Failure After Heart Bypass Surgery

Heart bypass surgery, also known as coronary artery bypass graft (CABG) surgery, creates a detour around the blocked part of a heart artery to restore blood supply to the heart muscle. The...

Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

The objective of the Symbiot III Clinical Trial was to evaluate the safety and effectiveness of the Symbiot Covered Stent System in the treatment of symptomatic ischemic saphenous vein byp...

Post Coronary Artery Bypass Graft (CABG) Study

To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft...

PubMed Articles [16046 Associated PubMed Articles listed on BioPortfolio]

Predictive Value of Mean Platelet Volume in Saphenous Vein Graft Disease.

To determine whether mean platelet volume (MPV), platelet distribution width (PDW), and platelet count could be used as determinants of mortality following coronary artery bypass graft (CABG) surgery ...

Successful aneurysm resection and coronary artery revascularization following saphenous vein graft aneurysm rupture.

Saphenous vein graft aneurysms after coronary artery bypass grafting (CABG) have been rarely reported. Their incidence and natural history are poorly defined. Herein, we present a patient who presente...

Use of Doppler Ultrasound for Saphenous Vein Mapping to Obtain Grafts for Coronary Artery Bypass Grafting.

The great saphenous vein is widely used as a graft in coronary artery bypass grafting surgery. Complications due to saphenous vein harvesting can be minimized when using ultrasonography mapping and ma...

Autologous Saphenous Vein Panel Graft For Vascular Reconstruction.

This study aims to present early and mid-term results of vascular reconstruction with saphenous vein panel graft.

Microenvironment of saphenous vein graft preservation prior to coronary artery bypass grafting.

The best preservation solution for a free vascular graft prior to coronary artery bypass grafting (CABG) remains controversial. The aim of this investigation was to evaluate the microenvironment of th...

Medical and Biotech [MESH] Definitions

The vein which drains the foot and leg.

Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.

An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.

A short thick vein formed by union of the superior mesenteric vein and the splenic vein.

The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

More From BioPortfolio on "Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial